Brief: Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For Vtama®
11/04/2025 13:57
April 11 (Reuters) - Conduit Pharmaceuticals Inc CDT.O: CONDUIT PHARMACEUTICALS ANNOUNCES NOVEL COCRYSTAL PATENT FILING FOR VTAMA® (TAPINAROF) WITH ENHANCED THERAPEUTIC AND MARKET EXTENSION PROSPECTS Source text: ID:nGNX3dZ2TK Further company coverage: CDT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CDT Equity
See all newsNASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: CDT Equity - Enters Securities Purchase Agreement With Sarborg Investors On July 30, 2026 - SEC Filing
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM